First-time generic approvals.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 177
- Publication type:
- Article
Works matching IS 1082801X AND DT 2012 AND VI 47 AND IP 5
Results: 11
1
2
Drug Watch.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 207
- Publication type:
- Article
3
Clinical studies review findings on triple-antiplatelet therapy after PCI, investigational thrombin receptor antagonist.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 184
- By:
- Publication type:
- Article
4
Apixaban: An orally active factor Xa inhibitor to prevent strokes and systemic embolism in patients with nonvalvular atrial fibrillation.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 180
- By:
- Publication type:
- Article
5
CMS' Hospital Compare quality reporting site did not affect mortality, study indicates.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 178
- By:
- Publication type:
- Article
6
FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 177
- Publication type:
- Article
7
New oral anticoagulants: Their impact on efficacy and safety in patients undergoing total hip and total knee replacement and their influence on postoperative management.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 197
- By:
- Publication type:
- Article
8
New formulation.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 176
- Publication type:
- Article
9
New molecular entity.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 176
- Publication type:
- Article
10
Pipeline preview.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 176
- Publication type:
- Article
11
Statins associated with decreased risk of depressive symptoms.
- Published in:
- Formulary, 2012, v. 47, n. 5, p. 175
- By:
- Publication type:
- Article